Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2011 1
2013 1
2015 1
2016 2
2017 1
2021 1
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection potentials in rat brains via antioxidant effect.
Kandil LS, Farid RM, ElGamal SS, Hanafy AS. Kandil LS, et al. Drug Dev Ind Pharm. 2021 May;47(5):735-740. doi: 10.1080/03639045.2021.1934861. Epub 2021 Jun 7. Drug Dev Ind Pharm. 2021. PMID: 34032549
In a previous study, GH was complexed with chitosan to prepare intranasal GH/chitosan complex nanoparticles (CX-NP2). ...METHODS: CX-NP2 dispersion and GH solution were administrated intranasally to male Wistar rats for 30 days (3 mg/kg/day). ...
In a previous study, GH was complexed with chitosan to prepare intranasal GH/chitosan complex nanoparticles (CX-NP2). ...METHO …
Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management.
Hanafy AS, Farid RM, Helmy MW, ElGamal SS. Hanafy AS, et al. Drug Deliv. 2016 Oct;23(8):3111-3122. doi: 10.3109/10717544.2016.1153748. Epub 2016 Mar 4. Drug Deliv. 2016. PMID: 26942549 Free article.
The current study aimed to investigate if the complexation reaction between GH and chitosan altered the pharmacological and toxicological profiles of the parent drug; GH. ...The intracellular localization of CX-NP2 within brain neurons was investigated using transmi …
The current study aimed to investigate if the complexation reaction between GH and chitosan altered the pharmacological and toxicolog …
Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
Hanafy AS, Farid RM, ElGamal SS. Hanafy AS, et al. Drug Dev Ind Pharm. 2015;41(12):2055-68. doi: 10.3109/03639045.2015.1062897. Epub 2015 Jul 2. Drug Dev Ind Pharm. 2015. PMID: 26133084
GH encapsulation efficiency and loading capacity were 23.34 and 9.86%, respectively. ...Rhodamine-labeled GH-CX-NPs were detected in the olfactory bulb, hippocampus, orbitofrontal and parietal cortices. ...
GH encapsulation efficiency and loading capacity were 23.34 and 9.86%, respectively. ...Rhodamine-labeled GH-CX-NPs were detec …
In situ detoxification and continuous cultivation of dilute-acid hydrolyzate to ethanol by encapsulated S. cerevisiae.
Talebnia F, Taherzadeh MJ. Talebnia F, et al. J Biotechnol. 2006 Sep 18;125(3):377-84. doi: 10.1016/j.jbiotec.2006.03.013. Epub 2006 Apr 18. J Biotechnol. 2006. PMID: 16621080
They produced ethanol with yield 0.44+/-0.01 g/g and specific productivity 0.14-0.17 g/(gh) at all dilution rates. Glycerol was the main by-product of the cultivations, which yielded 0.039-0.052 g/g. ...
They produced ethanol with yield 0.44+/-0.01 g/g and specific productivity 0.14-0.17 g/(gh) at all dilution rates. Glycerol was the m …
Children with isolated growth hormone deficiency: Empty sella versus normal sella.
Ismail NA, Metwaly NS, El-Moguy FA, Hafez MH, El Dayem SM, Farid TM. Ismail NA, et al. Indian J Hum Genet. 2013 Apr;19(2):130-5. doi: 10.4103/0971-6866.116102. Indian J Hum Genet. 2013. PMID: 24019611 Free PMC article.
The need for replacement hormone therapy in ES, as in other syndromes that may cause hypopituitarism, must be assessed for every single hormone, including growth hormone (GH). AIM: To determine whether or not the presence of ES could allow some changes in the GH res …
The need for replacement hormone therapy in ES, as in other syndromes that may cause hypopituitarism, must be assessed for every single horm …